Drugs / VAX161
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01560793 | Jun 2012 → Jun 2013 | influenza | VaxInnate Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VAX161 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01560793 ↗ |
| Known as | STF2.HA5 H5N1 | “VAX161 [STF2.HA5 H5N1]” NCT01560793 ↗ |